|
 |
COVID-19 has further highlighted the importance of effective treatments for different conditions. Together, researchers have developed vaccines for COVID-19 that will save countless lives by preventing infection. Antibiotics are an example of another revolutionary and life-saving medical
development. However, antibiotic resistance is on the rise, with drug-resistant bacteria becoming less responsive to antibiotics. This is a serious problem that requires urgent solutions. Associate Professor Mitsuoki Kawano, Department of Human Nutrition, Chugokugakuen University, Japan, is
working to develop a novel antimicrobial method to tackle Antimicrobial resistance (AMR). He and his team are developing a technology that uses antisense RNA to control bacterial gene expression. Kawano also wishes to limit the damage caused to indigenous bacteria and intestinal flora by existing
antibacterial drugs, To do this, he and the team are developing a method that can prevent the transmissive plasmid from being transmitted to other bacteria. The researchers have developed a system that can inhibit cell growth by suppressing the synthesis of proteins that are essential for
bacterial growth through the action of antisense RNA transcribed from phagemid nucleic acid introduced into bacteria by phage infection.
記事・総説・解説・論説等(商業誌、新聞、ウェブメディア)
